These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9146668)

  • 1. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
    Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
    J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
    Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
    Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
    Nistér M; Libermann TA; Betsholtz C; Pettersson M; Claesson-Welsh L; Heldin CH; Schlessinger J; Westermark B
    Cancer Res; 1988 Jul; 48(14):3910-8. PubMed ID: 2454731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
    Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
    Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
    Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
    Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
    Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
    Walker C; Everitt J; Freed JJ; Knudson AG; Whiteley LO
    Cancer Res; 1991 Jun; 51(11):2973-8. PubMed ID: 2032234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
    Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor secretion of growth factors.
    Daughaday WH; Deuel TF
    Endocrinol Metab Clin North Am; 1991 Sep; 20(3):539-63. PubMed ID: 1718747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.
    Atlas I; Mendelsohn J; Baselga J; Fair WR; Masui H; Kumar R
    Cancer Res; 1992 Jun; 52(12):3335-9. PubMed ID: 1596891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TNF-alpha and retinoic acid on the proliferation of the clear cell and chromophilic types of human renal cell carcinoma in vitro.
    Gerharz CD; Ramp U; Reinecke P; Ressler U; Dienst M; Marx N; Friebe U; Engers R; Pollow K; Gabbert HE
    Anticancer Res; 1996; 16(4A):1633-41. PubMed ID: 8712681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK; Hu C; Baker VV
    Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene.
    Huang SA; Lin PF; Fan D; Price JE; Trujillo JM; Chakrabarty S
    J Cell Physiol; 1991 Aug; 148(2):220-7. PubMed ID: 1880151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIGH3 is overexpressed in clear cell renal cell carcinoma.
    Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
    Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
    Rodeck U; Williams N; Murthy U; Herlyn M
    J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
    Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
    J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line.
    Fernandez-Pol JA; Klos DJ; Hamilton PD; Talkad VD
    Cancer Res; 1987 Aug; 47(16):4260-5. PubMed ID: 3496959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.